Vycor Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020
May 12, 2020 at 01:13 pm EDT
Share
Vycor Medical, Inc. announced earnings results for the first quarter ended March 31, 2020. For the first quarter, the company announced sales was USD 351,051 compared to USD 350,666 a year ago. Operating loss was USD 156,391 compared to USD 162,838 a year ago. Net loss was USD 174,948 compared to USD 180,298 a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.
Vycor Medical, Inc. provides surgical and therapeutic solutions. The Company designs, develops and markets neurological medical devices and therapies. The Company operates through two segments: Vycor Medical and NovaVision. The Vycor Medical segment designs, develops and markets medical devices for use in neurosurgery. The NovaVision segment provides non-invasive rehabilitation therapies for those who have vision disorders resulting from neurological brain damage such as that caused by a stroke. Vycor Medical's product Vycor Medical's ViewSite Brain Access System (VBAS) is a next generation retraction and access system. Vycor Medical focuses on brain and cervical surgical access systems for sale to hospitals and medical professionals. NovaVision's products include Vision Restoration Therapy (VRT), NeuroEyeCoach and Neuro-Eye Therapy (NeEt). The Company operates in the United States and Europe.
VYCOR MEDICAL, INC. 
